2015 Beta-O2 Technologies Ltd.
<p>Feb 18, 2015 09:50 PM see their Sci references page... many current refs on encapsulation.</p>
<p>
consume 80% of O2 coming into pancreas
phase 1 Uppsala; will launch in Europe in 2017/2018;</p>
<p>
<b>Dan Gelvan</b>... see interview with him; Nov 25 2014;</p>
<p>
the Beta-air bio-artif pancreas contains islets</p>
<p>
cells implanted in a hydrogel struc</p>
<p>
Islets: <b> one of biggest consumers of O2 in the body.</b>
<b>2% of organ but consume 80% of oxygen of the pancreas.</b></p>
<p>
cells produce insulin and glucagon.</p>
<p>
Interview Bloomberg TV:</p>
<p>
350M people with DM world;
3M T1DM in USA and 17M world.</p>
<p>
Tel Aviv: device is Beta-Air;</p>
<p>
got 500K bucks from JDRF for trial in Sweden. 8 pts over 2 years.
did first pt already: keep it in for 180 days. monthly checkups.</p>
<p>
company will use human stem cells from other partners and from animal-dericed cells.</p>
<p>
conventional iselts last for 8 to 9 years. hoping will last even longer!!!</p>
<p>
see the article in Israeli press by Abigail;
see the Diabetes Daily article.</p>
<p>
</p>
<p>
</p>
<p>
</p>
<p>
</p>
<p>
</p>